Skip to main content

AL Naleway

First name:
AL
Last name:
Naleway
Henninger, M. ., Kuntz, J. ., Firemark, A. ., Varga, A. ., Bok, K. ., & Naleway, A. . (2018). Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccination. Vaccine, 36(27), 3937-3942. https://doi.org/10.1016/j.vaccine.2018.05.070 (Original work published 2018)
Kuntz, J. ., Crane, B. ., Weinmann, S. ., Naleway, A. ., & Investigator, T. V. S. D. (2018). Myocarditis and pericarditis are rare following live viral vaccinations in adults. Vaccine, 36(12), 1524-1527. https://doi.org/10.1016/j.vaccine.2018.02.030 (Original work published 2018)
Donahue, J. ., Kieke, B. ., King, J. ., DeStefano, F. ., Mascola, M. ., Irving, S. ., … Belongia, E. . (2017). Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12. Vaccine, 35(40), 5314-5322. https://doi.org/10.1016/j.vaccine.2017.06.069 (Original work published 2017)
Henninger, M. ., Mcmullen, C. ., Firemark, A. ., Naleway, A. ., Henrikson, N. ., & Turcotte, J. . User-Centered Design for Developing Interventions to Improve Clinician Recommendation of Human Papillomavirus Vaccination. The Permanente Journal, 21. https://doi.org/10.7812/TPP/16-191 (Original work published 2017)
Vickers, E. ., McClure, D. ., Naleway, A. ., Jacobsen, S. ., Klein, N. ., Glanz, J. ., … Belongia, E. . (2017). Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink. Vaccine, 35(43), 5872-5877. https://doi.org/10.1016/j.vaccine.2017.08.086 (Original work published 2017)